Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    iTeos Therapeutics Inc.

    NASDAQ: ITOS · Real-Time Price · USD
    10.16
    -0.02 (-0.20%)
    At close: Jun 06, 2025, 3:51 PM

    iTeos Therapeutics Statistics

    Share Statistics

    iTeos Therapeutics has 38.27M shares outstanding. The number of shares has increased by 5.73% in one year.

    Shares Outstanding

    n/a
    		 38.27M

    Shares Change (YoY)

    n/a
    		 5.73%

    Shares Change (QoQ)

    n/a
    		 4.54%

    Owned by Institutions (%)

    n/a
    		 79.13%

    Shares Floating

    n/a
    		 n/a

    Failed to Deliver (FTD) Shares

    n/a
    		 350

    FTD / Avg. Volume

    n/a
    		 0.03%

    Short Selling Information

    The latest short interest is 2.74M, so 7.16% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 2.74M

    Short % of Shares Out

    n/a
    		 7.16%

    Short % of Float

    n/a
    		 9.21%

    Short Ratio (days to cover)

    n/a
    		 1.23

    Valuation Ratios

    The PE ratio is -2.31 and the forward PE ratio is -6.5. iTeos Therapeutics's PEG ratio is -0.43.

    PE Ratio

    n/a
    		 -2.31

    Forward PE

    n/a
    		 -6.5

    PS Ratio

    n/a
    		 8.88

    Forward PS

    n/a
    		 2.6

    PB Ratio

    n/a
    		 0.53

    P/FCF Ratio

    n/a
    		 -3.11

    PEG Ratio

    n/a
    		 -0.43
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for iTeos Therapeutics.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 12.62, with a Debt / Equity ratio of 0.01.

    Current Ratio

    n/a
    		 12.62

    Quick Ratio

    n/a
    		 12.62

    Debt / Equity

    n/a
    		 0.01

    Debt / EBITDA

    n/a
    		 -0.03

    Debt / FCF

    n/a
    		 -0.05

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $202,312.14

    Profits Per Employee

    n/a
    		 $-776,959.54

    Employee Count

    n/a
    		 173

    Asset Turnover

    n/a
    		 0.05

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 14.07M

    Effective Tax Rate

    n/a
    		 -11.69%

    Stock Price Statistics

    The stock price has increased by -39.58% in the last 52 weeks. The beta is 1.51, so iTeos Therapeutics's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.51

    52-Week Price Change

    n/a
    		 -39.58%

    50-Day Moving Average

    n/a
    		 7.29

    200-Day Moving Average

    n/a
    		 8.83

    Relative Strength Index (RSI)

    n/a
    		 74.45

    Average Volume (20 Days)

    n/a
    		 1,181,888

    Income Statement

    In the last 12 months, iTeos Therapeutics had revenue of 35M and earned -134.41M in profits. Earnings per share was -3.32.

    Revenue

    n/a
    		 35M

    Gross Profit

    n/a
    		 33.76M

    Operating Income

    n/a
    		 -159.53M

    Net Income

    n/a
    		 -134.41M

    EBITDA

    n/a
    		 -159.53M

    EBIT

    n/a
    		 -154.32M

    Earnings Per Share (EPS)

    n/a
    		 -3.32
    Full Income Statement

    Balance Sheet

    The company has 142.13M in cash and 5.1M in debt, giving a net cash position of 137.03M.

    Cash & Cash Equivalents

    n/a
    		 142.13M

    Total Debt

    n/a
    		 5.1M

    Net Cash

    n/a
    		 137.03M

    Retained Earnings

    n/a
    		 -9.78M

    Total Assets

    n/a
    		 658.87M

    Working Capital

    n/a
    		 499.05M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -98.18M and capital expenditures -1.63M, giving a free cash flow of -99.81M.

    Operating Cash Flow

    n/a
    		 -98.18M

    Capital Expenditures

    n/a
    		 -1.63M

    Free Cash Flow

    n/a
    		 -99.81M

    FCF Per Share

    n/a
    		 -2.47
    Full Cash Flow Statement

    Margins

    Gross margin is 96.46%, with operating and profit margins of -455.79% and -384.04%.

    Gross Margin

    n/a
    		 96.46%

    Operating Margin

    n/a
    		 -455.79%

    Pretax Margin

    n/a
    		 -343.83%

    Profit Margin

    n/a
    		 -384.04%

    EBITDA Margin

    n/a
    		 -455.79%

    EBIT Margin

    n/a
    		 -455.79%

    FCF Margin

    n/a
    		 -285.18%

    Dividends & Yields

    ITOS does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for ITOS is $12, which is 18.2% higher than the current price. The consensus rating is "Hold".

    Price Target

    n/a
    		 $12

    Price Target Difference

    n/a
    		 18.2%

    Analyst Consensus

    n/a
    		 Hold

    Analyst Count

    n/a
    		 6
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 2.59

    Piotroski F-Score

    n/a
    		 4

    Add to Watchlist